Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy for the treatment of pediatric brain tumors: a narrative review. | Transl Pediatr | 2022 | 36643672 | PubTator, text mining | PubMed |
| Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review. | JACC CardioOncol | 2022 | 36636439 | PubTator, text mining | PubMed |
| Use of a maturity model for facilitating the introduction of CAR T-cell therapy-Results of the START CAR-T project. | Glob Reg Health Technol Assess | 2022 | 36628303 | PubTator, text mining | PubMed |
| Activation of cancer immunotherapy by nanomedicine. | Front Pharmacol | 2022 | 36618938 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cell therapy for multiple myeloma. | Front Immunol | 2022 | 36618390 | PubTator, text mining | PubMed |
| Interleukin-15 and chemokine ligand 19 enhance cytotoxic effects of chimeric antigen receptor T cells using zebrafish xenograft model of gastric cancer. | Front Immunol | 2022 | 36618357 | PubTator, text mining | PubMed |
| Leveraging Natural Killer Cell Innate Immunity against Hematologic Malignancies: From Stem Cell Transplant to Adoptive Transfer and Beyond. | Int J Mol Sci | 2022 | 36613644 | PubTator, text mining | PubMed |
| Towards Novel Gene and Cell Therapy Approaches for Cervical Cancer. | Cancers (Basel) | 2022 | 36612258 | PubTator, text mining | PubMed |
| Adoptive Cell Therapy for T-Cell Malignancies. | Cancers (Basel) | 2022 | 36612092 | PubTator, text mining | PubMed |
| Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia. | Front Immunol | 2022 | 36605213 | PubTator, text mining | PubMed |
| Editorial: Engineered immune cells in cancer immunotherapy (EICCI). | Front Immunol | 2022 | 36605186 | PubTator, text mining | PubMed |
| Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer. | Front Immunol | 2022 | 36601109 | PubTator, text mining | PubMed |
| The emerging role of regulatory cell-based therapy in autoimmune disease. | Front Immunol | 2022 | 36591309 | PubTator, text mining | PubMed |
| Immunomodulatory role of metalloproteases in cancers: Current progress and future trends. | Front Immunol | 2022 | 36591235 | PubTator, text mining | PubMed |
| Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in veterinary medicine: Recent advances (2019-present). | Vet World | 2022 | 36590115 | PubTator, text mining | PubMed |
| Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data. | Front Mol Biosci | 2022 | 36582202 | PubTator, text mining | PubMed |
| The Yearbook: 11 early-career researchers to watch. | Nat Med | 2022 | 36581748 | PubTator, text mining | PubMed |
| Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction. | Front Cell Dev Biol | 2022 | 36578789 | PubTator, text mining | PubMed |
| Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy. | Int J Nanomedicine | 2022 | 36575698 | PubTator, text mining | PubMed |
| Serious adverse events and coping strategies of CAR-T cells in the treatment of malignant tumors. | Front Immunol | 2022 | 36569917 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=47